Gilead Sciences Inc (GILD)
Return on assets (ROA)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 480,000 | 5,665,000 | 4,592,000 | 6,225,000 | 89,000 |
Total assets | US$ in thousands | 58,995,000 | 62,125,000 | 63,171,000 | 67,952,000 | 68,407,000 |
ROA | 0.81% | 9.12% | 7.27% | 9.16% | 0.13% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $480,000K ÷ $58,995,000K
= 0.81%
Based on the data provided, the return on assets (ROA) for Gilead Sciences Inc has shown significant fluctuations over the last five years, ranging from 0.13% to 9.16%.
In 2020, the ROA was only 0.13%, indicating that the company generated a minimal return on its assets compared to its total assets. However, there was a substantial increase in 2021, with the ROA jumping to 9.16%, suggesting a significant improvement in asset utilization efficiency and profitability.
Despite the positive performance in 2021, the ROA dropped to 7.27% in 2022 and then slightly increased to 9.12% in 2023. These fluctuations might indicate changes in the company's operational efficiency, asset management, or profitability during these years.
In 2024, the ROA decreased to 0.81%, signifying a significant decline in the company's ability to generate profits from its assets compared to the previous year.
Overall, it is essential for Gilead Sciences Inc to monitor and analyze its ROA consistently to ensure efficient asset utilization, profitability, and sustainable growth in the future.
Peer comparison
Dec 31, 2024